Zobrazeno 1 - 10
of 82
pro vyhledávání: '"Florent, Puisset"'
Autor:
Florent Puisset, Emmanuel Raffoux, Lionel Ades, Tony Huynh, Raphaël Itzykson, Didier Bouscary, Loréa Aguinana, Florence Rabian, Marie Sebert, Anne Vekhoff, Eolia Brissot, Mohamad Mohty, Agnes Bonnin, Alexis Genthon, Jeremie Zerbit, Lise Willems, Justine Decrocq, Adrien Contejean, Etienne Lengline, Samia Mourah, Lauriane Goldwirt
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Not available.
Externí odkaz:
https://doaj.org/article/c437c3084c634ebcb4d95ad5e386be50
Autor:
Louise Laloi, Natacha Chaumard Billotey, Pierre‐Yves Dumas, Franciane Paul, Alban Villate, Célestine Simand, Luc Fornecker, Florent Puisset, Sarah Bertoli, Marion Boissard Simonet, Kamel Laribi, Dyhia Houyou, Alberto Santagostino, Claire Michel, Gabrielle Roth Guepin, Elodie Guerineau, Reza Tabrizi, Mathilde Hunault, Aurélien Giltat, Eléonore Kaphan, Claude Bulabois, Elodie Cartet, Clément Rocher, Florence Lachenal, Stéphane Morisset, Christian Récher, Arnaud Pigneux, Amine Belhabri, Mauricette Michallet, Anne‐Sophie Michallet
Publikováno v:
Cancer Medicine, Vol 12, Iss 6, Pp 7175-7181 (2023)
Abstract Background Recently, the combination of venetoclax plus a hypomethylating agent (HMA; azacitidine ordecitabine) or low‐dose cytarabine (LDAC) showed promise in Phase III trials in previously untreated AML. In France at the time of this stu
Externí odkaz:
https://doaj.org/article/63f3a6ecd43b4f86b0b0537085a06afc
Autor:
Félicien Le Louedec, Florent Puisset, Fabienne Thomas, Étienne Chatelut, Mélanie White‐Koning
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 10, Pp 1208-1220 (2021)
Abstract Pharmacokinetic (PK) parameter estimation is a critical and complex step in the model‐informed precision dosing (MIPD) approach. The mapbayr package was developed to perform maximum a posteriori Bayesian estimation (MAP‐BE) in R from any
Externí odkaz:
https://doaj.org/article/c86571642f3042ac94a9ffd97f1904dc
Autor:
Caroline Imbert, Anne Montfort, Marine Fraisse, Elie Marcheteau, Julia Gilhodes, Elodie Martin, Florie Bertrand, Marlène Marcellin, Odile Burlet-Schiltz, Anne Gonzalez de Peredo, Virginie Garcia, Stéphane Carpentier, Sophie Tartare-Deckert, Pierre Brousset, Philippe Rochaix, Florent Puisset, Thomas Filleron, Nicolas Meyer, Laurence Lamant, Thierry Levade, Bruno Ségui, Nathalie Andrieu-Abadie, Céline Colacios
Publikováno v:
Nature Communications, Vol 11, Iss 1, Pp 1-14 (2020)
There are many patients who do not respond to immune checkpoint inhibitor (ICI) immunotherapy. Here, the authors show a significant negative correlation between sphingosine kinase-1 (SK1) expression and survival for ICI-treated melanoma patients, and
Externí odkaz:
https://doaj.org/article/38bb744217484cb7ab770593454d6238
Publikováno v:
Clinical Pharmacokinetics. 62:55-66
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4f2e42607cb319e79869950858413ba3
https://doi.org/10.1007/s40262-022-01200-8
https://doi.org/10.1007/s40262-022-01200-8
Autor:
Louise Laloi, Natacha Chaumard Billotey, Pierre‐Yves Dumas, Franciane Paul, Alban Villate, Célestine Simand, Luc Fornecker, Florent Puisset, Sarah Bertoli, Marion Boissard Simonet, Kamel Laribi, Dyhia Houyou, Alberto Santagostino, Claire Michel, Gabrielle Roth Guepin, Elodie Guerineau, Reza Tabrizi, Mathilde Hunault, Aurélien Giltat, Eléonore Kaphan, Claude Bulabois, Elodie Cartet, Clément Rocher, Florence Lachenal, Stéphane Morisset, Christian Récher, Arnaud Pigneux, Amine Belhabri, Mauricette Michallet, Anne‐Sophie Michallet
Publikováno v:
Cancer Medicine. 12:7175-7181
Recently, the combination of venetoclax plus a hypomethylating agent (HMA; azacitidine ordecitabine) or low-dose cytarabine (LDAC) showed promise in Phase III trials in previously untreated AML. In France at the time of this study, venetoclax was not
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::07ccbed253fa59f84b89897f97c79079
https://doi.org/10.1002/cam4.5459
https://doi.org/10.1002/cam4.5459
Autor:
Félicien Le Louedec, Fanny Gallais, Fabienne Thomas, Mélanie White-Koning, Ben Allal, Caroline Protin, Loïc Ysebaert, Étienne Chatelut, Florent Puisset
Publikováno v:
Pharmaceuticals, Vol 14, Iss 2, p 162 (2021)
Therapeutic drug monitoring of ibrutinib is based on the area under the curve of concentration vs. time (AUCIBRU) instead of trough concentration (Cmin,ss) because of a limited accumulation in plasma. Our objective was to identify a limited sampling
Externí odkaz:
https://doaj.org/article/55cf8a5bddb5425db85465e59fc53d4c
Autor:
Florent Puisset, Félicien Le Louedec, Florence Dalenc, Lorène Verguet, Eleonora De Maio, Jean Louis Lacaze, Marion Montastruc, Mony Ung, Camille Vinson, Sophie Perriat, Sandrine Pacher, Etienne Chatelut, Mélanie White Koning
Publikováno v:
British Journal of Clinical Pharmacology.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::36bb36b307ab21503bf242bf308eba95
https://doi.org/10.1111/bcp.15702
https://doi.org/10.1111/bcp.15702
Autor:
Florent Puisset, Mourad Mseddi, Loïc Mourey, Damien Pouessel, Benoit Blanchet, Etienne Chatelut, Christine Chevreau
Publikováno v:
Cancers. 15(1)
Seven tyrosine kinase inhibitor compounds with anti-angiogenic properties remain key drugs to treat advanced renal cell carcinoma. There is a strong rationale to develop therapeutic drug monitoring for these drugs. General considerations of such moni
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0c9d8c6026b4a3dac45eafeef320a8f1
https://pubmed.ncbi.nlm.nih.gov/36612311
https://pubmed.ncbi.nlm.nih.gov/36612311
Autor:
Etienne Chatelut, Fabienne Thomas, Félicien Le Louedec, Florent Puisset, Melanie White-Koning
Publikováno v:
CPT: Pharmacometrics & Systems Pharmacology
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 10, Pp 1208-1220 (2021)
CPT: Pharmacometrics & Systems Pharmacology, Vol 10, Iss 10, Pp 1208-1220 (2021)
Pharmacokinetic (PK) parameter estimation is a critical and complex step in the model‐informed precision dosing (MIPD) approach. The mapbayr package was developed to perform maximum a posteriori Bayesian estimation (MAP‐BE) in R from any populati
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f2d0b382d0dcf818670e39120f5b2ee2
http://europepmc.org/articles/PMC8520754
http://europepmc.org/articles/PMC8520754